Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T L Smith

Showing results (441-450 of 463) with videos related to

Pageof 47
Sort By:
American Journal of Physiology. Endocrinology and Metabolism|December 20, 2000
Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulin-resistant ratsB B Yaspelkis, J R Davis, M Saberi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancerA U Buzdar, G N Hortobagyi, S W Kau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patientsT M Tuttle, B W Anderson, W E Thompson, et al.
The American Journal of Medicine|May 1, 1986
Acute promyelocytic leukemia. M.D. Anderson Hospital experienceH M Kantarjian, M J Keating, R S Walters, et al.
Cancer|February 1, 1984
Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trialA U Buzdar, G R Blumenschein, T L Smith, et al.
Breast Cancer Research and Treatment|November 6, 2004
Expression of sigma 1 receptor in human breast cancerB Wang, R Rouzier, C T Albarracin, et al.
Cancer|August 1, 1991
Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosisA A Sahin, J Ro, J Y Ro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabineH M Kantarjian, S O'Brien, T L Smith, et al.
The New England Journal of Medicine|February 18, 1999
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working GroupT L Smith, M L Pearson, K R Wilcox, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 1999
Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteriaC S Ha, V Kavadi, M A Dimopoulos, et al.
Pageof 47

Showing results (441-450 of 463) with videos related to

Sort By:
Pageof 47
American Journal of Physiology. Endocrinology and Metabolism|December 20, 2000
Leptin administration improves skeletal muscle insulin responsiveness in diet-induced insulin-resistant ratsB B Yaspelkis, J R Davis, M Saberi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 1, 1992
Adjuvant therapy with escalating doses of doxorubicin and cyclophosphamide with or without leukocyte alpha-interferon for stage II or III breast cancerA U Buzdar, G N Hortobagyi, S W Kau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 26, 1998
Proliferative and cytokine responses to class II HER-2/neu-associated peptides in breast cancer patientsT M Tuttle, B W Anderson, W E Thompson, et al.
The American Journal of Medicine|May 1, 1986
Acute promyelocytic leukemia. M.D. Anderson Hospital experienceH M Kantarjian, M J Keating, R S Walters, et al.
Cancer|February 1, 1984
Adjuvant chemotherapy with fluorouracil, doxorubicin, and cyclophosphamide, with or without Bacillus Calmette-Guerin and with or without irradiation in operable breast cancer. A prospective randomized trialA U Buzdar, G R Blumenschein, T L Smith, et al.
Breast Cancer Research and Treatment|November 6, 2004
Expression of sigma 1 receptor in human breast cancerB Wang, R Rouzier, C T Albarracin, et al.
Cancer|August 1, 1991
Ki-67 immunostaining in node-negative stage I/II breast carcinoma. Significant correlation with prognosisA A Sahin, J Ro, J Y Ro, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 24, 1999
Treatment of Philadelphia chromosome-positive early chronic phase chronic myelogenous leukemia with daily doses of interferon alpha and low-dose cytarabineH M Kantarjian, S O'Brien, T L Smith, et al.
The New England Journal of Medicine|February 18, 1999
Emergence of vancomycin resistance in Staphylococcus aureus. Glycopeptide-Intermediate Staphylococcus aureus Working GroupT L Smith, M L Pearson, K R Wilcox, et al.
International Journal of Radiation Oncology, Biology, Physics|February 25, 1999
Hodgkin's disease with lymphocyte predominance: long-term results based on current histopathologic criteriaC S Ha, V Kavadi, M A Dimopoulos, et al.
Pageof 47